CUL3 and NRF2 mutations confer an NRF2 activation phenotype in a sporadic form of papillary renal cell carcinoma

by Ooi, A., Dykema, K., Ansari, A., Petillo, D., Snider, J., Kahnoski, R., Anema, J., Craig, D., Carpten, J., Teh, B.-T., Furge, K.A.
Published 2016

Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell Carcinoma

by Wei, X, Choudhury, Y, Lim, W.K, Anema, J, Kahnoski, R.J, Lane, B, Ludlow, J, Takahashi, M, Kanayama, H.-O, Belldegrun, A, Kim, H.L, Rogers, C, Nicol, D, Teh, B.T, Tan, M.-H
Published 2020

A molecular classification of papillary renal cell carcinoma

by Yang, X.J, Tan, M.-H, Kim, H.L, Ditlev, J.A, Betten, M.W, Png, C.E, Kort, E.J, Futami, K, Furge, K.A, Takahashi, M, Kanayama, H.-O, Tan, P.H, Teh, B.S, Luan, C, Wang, K, Pins, M, Tretiakova, M, Anema, J, Kahnoski, R, Nicol, T, Stadler, W, Vogelzang, N.G, Amato, R, Seligson, D, Figlin, R, Belldegrun, A, Rogers, C.G, Teh, B.T
Published 2020

Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma

by Varela, I., Tarpey, P., Raine, K., Huang, D., Ong, C.K., Stephens, P., Davies, H., Jones, D., Lin, M.-L., Teague, J., Bignell, G., Butler, A., Cho, J., Dalgliesh, G.L., Galappaththige, D., Greenman, C., Hardy, C., Jia, M., Latimer, C., Lau, K.W., Marshall, J., McLaren, S., Menzies, A., Mudie, L., Stebbings, L., Largaespada, D.A., Wessels, L.F.A., Richard, S., Kahnoski, R.J., Anema, J., A.tuveson, D., Perez-Mancera, P.A., Mustonen, V., Fischer, A., Adams, D.J., Rust, A., Chan-On, W., Subimerb, C., Dykema, K., Furge, K., Campbell, P.J., Teh, B.T., Stratton, M.R., Futreal, P.A.
Published 2016